ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2566

Using Abdominal CT-Derived Bone Mineral Density and Psoas Volume for Opportunistic Osteoporosis Screening and Fracture Risk Assessment

Ye Liu1, Hongke Wu1, Amy Mudano2, Omar Safarini1, John Eddins1, Carlos Cardenas1, Lesley Jackson1, Jeffrey Curtis3 and Steven Rothenberg1, 1University of Alabama at Birmingham, Birmingham, AL, 2Foundation for Advancing Science, Technology, Education and Research (FASTER), Hoover, AL, 3Foundation for Advancing Science, Technology, Education and Research, Birmingham, AL

Meeting: ACR Convergence 2025

Keywords: Computed tomography (CT), Dual energy x-ray absorptiometry (DEXA), osteoporosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2547–2566) ARP Posters I

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Osteoporosis (OP) is assessed by dual-energy X-ray absorptiometry (DXA) for bone mineral density (BMD). Computed tomography (CT) offers an alternative for “opportunistic” screening. This study evaluated the performance of CT-derived BMD alone and combined with psoas muscle mass to classify OP based on DXA and predict major osteoporotic fracture (MOF) risk based on FRAX.

Methods: Consecutive abdominal CT scans (2015–2018) of women with DXA available within 1 year of the CT exam were processed to quantify L1 vertebral attenuation and psoas muscle volume. T-scores and EHR data were extracted for age, race, and BMI. We obtained the lowest T score among lumbar spine, femoral neck, or total hip. OP was defined as the lowest T-score ≤ -2.5. CT BMD was defined as L1 attenuation in Hounsfield units. We fit 4 probit models to evaluate the discrimination ability of identifying OP: CT BMD alone (Model 1), CT BMD + psoas volume (Model 2), CT BMD + age + race + BMI (Model 3), and CT BMD + psoas volume + age + race + BMI (Model 4). AUROCs were used to compare discrimination. Clustered bootstrap was used to calculate 95% CI and compare AUROC, accounting for repeated scans. We then built a linear model to predict the lowest T-score from CT BMD, psoas volume, age, race, and BMI by 5-fold cross-validation, with results visualized in a nomogram. A subgroup analysis of women with full FRAX risk factor data available was performed, modeling MOF risk ≥20% as the outcome, using similar analytical approaches.

Results: A total of 1,761 CT scans linked with DXA were analyzed(mean age: 67.5 ± 9.7). ROC curves and AUROCs are shown in Figure 1. Discrimination was modest (AUROC 0.69) using the CT L1 BMD alone and appreciably improved after adding psoas volume (AUROC 0.75). The AUROC for CT L1 BMD, independent of age, BMI, and race, was 0.67 [0.63–0.71], and for psoas volume was 0.62 [0.59–0.66] (p = 0.11). The linear model predicting lowest T-score showed good discrimination (g-index=0.84) and calibration (slope=0.996; see nomogram in Figure 2). However, neither CT BMD alone (AUROC = 0.66 [0.55–0.76]) nor combined with psoas volume (AUROC = 0.66 [0.56–0.76], p = 0.69) effectively identified high MOF risk.

Conclusion: Adding psoas muscle volume to L1 CT BMD from abdominal CT performed for other purposes significantly improved OP classification compared to CT L1 attenuation alone. Combining muscle volume and BMD measures may improve incidental OP diagnosis accuracy for targeted interventions.

Supporting image 1Figure 1. Abdominal CT-derived BMD and psoas volume in osteoporosis assessment: ROC curve comparison between models for osteoporosis classification (lowest T-score <=-2.5 vs. > -2.5)

ROC curve comparison between models for osteoporosis classification (*: p < 0.001 vs. Model 1. ^: p=0.18 vs. Model 2. **: p=0.039 vs. Model 3. N&#3f1,442 women)

Supporting image 2Figure 2. Regression-based nomogram for linear model predicting lowest T-score among lumbar spine, femoral neck, or total hip based on CT L1 BMD, psoas volume, and clinical variables (age, BMI, race)


Disclosures: Y. Liu: Amgen, 5; H. Wu: None; A. Mudano: None; O. Safarini: None; J. Eddins: None; C. Cardenas: None; L. Jackson: None; J. Curtis: AbbVie, 2, 5, Amgen, 2, 5, AstraZeneca, 2, 5, Bendcare, 2, 5, Eli Lilly, 2, 5, Genentech, 2, 5, Glaxo Smith Kline, 2, 5, Horizon, 2, 5, Janssen, 2, 5, Novartis, 2, 5, Pfizer, 2, 5, Sanofi, 2, 5, Scipher medicine, 2, 5, SetPoint, 2, 5, UCB, 2, 5; S. Rothenberg: None.

To cite this abstract in AMA style:

Liu Y, Wu H, Mudano A, Safarini O, Eddins J, Cardenas C, Jackson L, Curtis J, Rothenberg S. Using Abdominal CT-Derived Bone Mineral Density and Psoas Volume for Opportunistic Osteoporosis Screening and Fracture Risk Assessment [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/using-abdominal-ct-derived-bone-mineral-density-and-psoas-volume-for-opportunistic-osteoporosis-screening-and-fracture-risk-assessment/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/using-abdominal-ct-derived-bone-mineral-density-and-psoas-volume-for-opportunistic-osteoporosis-screening-and-fracture-risk-assessment/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology